Related Experiment Video
Updated: May 26, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Regression Equation for Predicting Source Strength Detection Rate in Iodine-125 Seed Brachytherapy
Masato Takanashi1, Isao Kuroda2, Tatsuhiko Zama1
1Department of Radiology and Radiation Oncology, Tokyo Medical University Ibaraki Medical Center, Ami, JPN.
Medical physicists must verify iodine-125 (125I) seed activity for prostate cancer brachytherapy. This study validates a regression equation to ensure accurate source strength detection rates, improving treatment reliability.
Area of Science:
- Medical Physics
- Radiation Oncology
- Nuclear Medicine
Background:
- Prostate cancer incidence is rising globally, increasing demand for treatments like iodine-125 (125I) seed brachytherapy.
- Inaccurate source activity in 125I seeds can compromise treatment efficacy and patient safety.
- Low verification rates of seed activity and number in Japan necessitate improved quality assurance protocols.
Purpose of the Study:
- To validate a regression equation for predicting accurate source strength detection rates based on the number of radiation sources.
- To provide a reliable method for facilities to verify 125I seed activity, addressing challenges with single-seed assays in Japan.
Main Methods:
- Utilized a batch assay method with a well-type ionization chamber (CRC-15R) to measure source intensity detection rates.
- Collected data on AgX100 seeds and employed Microsoft Excel 2019 to calculate a regression equation correlating source number to detection rate.
- Established specific control limits (acceptance and intervention) for batch assay results.
Main Results:
- Developed and validated a regression equation to predict appropriate detection rates for varying numbers of 125I radiation sources.
- The study provides a practical alternative to single-seed assays for source strength verification in 125I brachytherapy.
Conclusions:
- The validated regression equation offers a crucial reference for facilities performing or planning 125I seed brachytherapy.
- Accurate source strength measurement is critical for ensuring the safety and effectiveness of prostate cancer brachytherapy.
More Related Videos
07:31Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020